Back to search

Article

Low-dose IL-2 reduces IL-21<sup>+</sup>T cells and induces a long-lived anti-inflammatory gene expression signature inversely modulated in COVID-19 patients

2022-04-05

Abstract excerpt

Despite early clinical successes, the mechanisms of action of low-dose interleukin-2 (LD-IL-2) immunotherapy remain only partly understood. Here, we examined the effects of interval administration of low-dose recombinant IL-2 (iLD-IL-2) using high-resolution, single-cell multiomics and flow cytometry. We confirmed that iLD-IL-2 selectively expands thymic-derived FOXP3 + HELIOS + Tregs and CD56 br NK cells, and sho...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3003a100-51db-5938-a61d-c2b063b8782f
DOI
10.1101/2022.04.05.22273167
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Low-dose IL-2 reduces IL-21<sup>+</sup>T cells and induces a long-lived anti-inflammatory gene expression signature inversely modulated in COVID-19 patientsDOI 10.1101/2022.04.05.22273167
Select a neighboring publication to make it the new centre.